Tesamorelin CAS:804475-66-9

Tesamorelin, (formerly known as TH9507), is a type of peptide called a -releasing factor (GHRF). GHRF causes to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy.

Tesamorelin (formerly known as TH9507) is a synthetic -releasing factor that stimulates the pituitary gland in the brain to secrete ; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC,. Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individua

Tesamorelin injection comes as a powder to be mixed with the liquid provided with your medication and injected subcutaneously (under the skin). It is usually injected once a day. Use tesamorelin injection at around the same time every day. Pazljivo sledite navodilom na nalepki na recept, in prosite svojega zdravnika ali farmacevta, da pojasni kateri koli del, ki ga ne razumete. Use tesamorelin injection exactly as directed. Ne uporabljajte ga več ali manj ali ga uporabljajte pogosteje, kot vam je predpisal zdravnik.

This drug is synthetic GHRF. It stimulates the production of growth hormone by binding to receptors on the cells of the anterior pituitary gland. These growth hormones affect metabolism and body shape. Tesamoline specifically targets fat accumulation in the abdominal area. Because this drug releases growth hormone, it should not be taken by people with active cancer.

The recommended dose of tesaraline is 2 mg daily by subcutaneous injection. The drug is usually injected into the abdomen. The injection site should be rotated to avoid scarring, navel and bruising.